Encyclopedia

One of the most commonly discussed two-peptide research pairings in the healing/recovery category, combining two peptides studied for tissue-repair activity through different proposed mechanisms.

Rationale

Proposed complementary mechanisms (TB-500 via actin sequestration; BPC-157 via NO/angiogenesis pathways). Combination is popular anecdotally but unsupported by controlled human data.

• TB-500

  Proposed to promote cell migration and angiogenesis via actin sequestration (thymosin beta-4 fragment).

  In this pairing, TB-500 and BPC-157 are typically dosed independently at each peptide's own studied range and injection frequency; there is no established dose relationship between them beyond co-administration.

  Animal wound-healing / cardiac studies (full-length Tβ4, systemic)

  Frequency

  varies

  Commonly cited community/clinic loading pattern (TB-500 fragment) — NOT validated

  Dose

  2–2.5 mg

  Frequency

  1-2x weekly (anecdotal)

• BPC-157

  Proposed gastroprotective and angiogenic peptide via nitric-oxide pathway signaling; one of the most frequently stacked research peptides.

  Rat tendon/ligament injury models (intraperitoneal, once daily)

  Dose

  10 mcg/kg

  Frequency

  once daily

  Reported human intra-articular case observations (knee)

  Dose

  2–4 mcg

  Frequency

  unspecified